To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Introduced
Moved
Reached a final decision
Introduced 2025-04-28
Derived from the official record below.
Officially: “To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.” Read the full text
Science, Technology, Communications
What it does
Nucleic Acid Standards for Biosecurity Act This bill explicitly requires the National Institute of Standards and Technology (NIST) to support the development of best practices and technical standards for nucleic acid synthesis. Nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), carry genetic information within cells. Nucleic acid synthesis is the process of designing and creating custom nucleic acids; it is used in the development of medications and agricultural products. However, this technology also poses a risk of misuse (e.g., the intentional or unintentional
Summary by the Congressional Research Service, from the official record. Plain-language AI rewrite coming. Not legal advice.
Where it is
Introduced · 2025-04-28
In the House.
Passed the House · 2026-07-20
Senate floor vote · next
Official documents
Full bill textas published by GovInfo
officialCongressional Budget Office cost estimatewhat it would cost, by the nonpartisan CBO
officialThe numbers
29%
of bills that passed one chamber became law in the 118th Congress, 2023 to 2024 (n=939)
4
sponsors, out of 218 needed to pass
Who is lobbying on this
BCBSM INCvia BCBSM, INC.
2 filingsBLUE CROSS AND BLUE SHIELD ASSOCIATIONvia BLUE CROSS AND BLUE SHIELD ASSOCIATION
2 filingsBLUE CROSS AND BLUE SHIELD OF FLORIDA INCvia BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.
2 filingsBLUE CROSS AND BLUE SHIELD OF KANSAS INCvia BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.
2 filingsBLUE CROSS BLUE SHIELD OF MICHIGANvia BLUE CROSS BLUE SHIELD OF MICHIGAN
2 filingsTWIST BIOSCIENCE CORPORATIONvia IPOLICY SOLUTIONS
1 filingFrom 11 filings in federal lobbying disclosures (LDA), via lda.gov, naming this bill (2025). Filings are self-reported by lobbying firms and show who is paid to influence this bill. They do not say which side, or whether it worked.
Every fact on this page links to its source, starting with the official bill record. Last action: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation. (2026-07-21).